Diabetes
News
New study of diabetes drug for COVID-19 raises eyebrows
News
SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit
News
COVID-19 cases highlight longstanding racial disparities in health care
Data on higher infection and death rates in African Americans from COVID-19 may serve as a call to action.
News
Inflammatory markers may explain COVID-19, diabetes dynamic
Higher levels of markers may signal greater susceptibility to cytokine storm.
News
Dapagliflozin trial in CKD halted because of high efficacy
An independent data monitoring committee recommended stopping the trial.
News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
News
Keep calm: Under 25s with diabetes aren't being hospitalized for COVID-19
But some are concerned that type 1 diabetes diagnoses are being delayed.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2...
News
Treating COVID-19 in patients with diabetes
Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.
News
COVID-19: Extra caution needed for patients with diabetes
Coexisting heart disease, kidney disease, advanced age, and frailty are likely to further increase the severity of disease.